Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 12, 2001
April 27, 2020
c479f7a0-a940-4f91-b4b6-db286a5af68b
Related Documents
Submitting Debarment Certification Statements
Guidance DocumentOctober 2, 1998Center for Drug Evaluation and Research
How to Comply with the Pediatric Research Equity Act
Guidance DocumentSeptember 7, 2005Center for Drug Evaluation and Research
Applications Covered by Section 505(b)(2)
Guidance DocumentDecember 8, 1999Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox